推薦此記錄: C049 | PEGASPARGASE ADMINISTRATION AND TOLERABILITY IN PATIENTS AGED 55 YEARS OR OLDER WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE LAL1913 PROGRAM. A SUBANALYSIS OF THE CAMPUS ALL-LAL1913 STUDY.